By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Calithera Biosciences, Inc. 

7000 Shoreline Court
Suite 255
South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
SSF's Calithera Biosciences, Inc. (CALA) Prices IPO At $10 A Share, Below The Range 10/2/2014 8:20:10 AM
South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO 8/26/2014 6:24:25 AM
Calithera Biosciences, Inc. Presents Pharmacodynamic Data On CB-839 At The 2014 American Association for Cancer Research Annual Meeting 4/8/2014 6:47:50 AM
Calithera Biosciences, Inc. To Present Data On CB-839 At The American Association for Cancer Research Annual Meeting 2014 4/1/2014 6:44:24 AM
Calithera Biosciences, Inc. Appoints William D. Waddill Chief Financial Officer 3/25/2014 7:10:50 AM
Calithera Biosciences, Inc. Presents Preclinical Data For CB-839 Activity And Glutaminase Inhibition In Solid And Hematologic Tumors 3/18/2014 10:38:46 AM
Calithera Biosciences, Inc. Initiates Three Phase 1 Trials With First-In-Class Glutaminase Inhibitor CB-839 In Patients With Advanced Solid And Hematological Cancers 2/24/2014 11:11:27 AM
Calithera Biosciences, Inc. Presents Data For CB-839 In Triple-Negative Breast Cancer Models At The 2013 San Antonio Breast Cancer Symposium 12/12/2013 11:19:40 AM
Calithera Biosciences, Inc. Presents Preclinical Data For CB-839 At The 55th American Society of Hematology Annual Meeting 12/10/2013 7:12:53 AM
Calithera Biosciences, Inc. To Present Data At The 55th American Society For Hematology Annual Meeting And The 2013 San Antonio Breast Cancer Symposium 11/26/2013 7:24:45 AM
12
//-->